PPARδ and its ligand EA had beneficial effects in the treatment of neuroectodermal tumors and Parkinson's disease and EA has potential anti-cancer and neuroprotective effects [30]. The gene discussed is PPARD; the disease is primitive neuroectodermal tumor.